| Guidelines for the use and interpretation of assays for monitoring autophagy DJ Klionsky, FC Abdalla, H Abeliovich, RT Abraham, A Acevedo-Arozena, ... Autophagy 12 (1), 1-222, 2016 | 13274* | 2016 |
| Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19 Y Huang, C Yang, X Xu, W Xu, S Liu Acta Pharmacologica Sinica 41 (9), 1141-1149, 2020 | 2254 | 2020 |
| The spike protein of SARS-CoV—a target for vaccine and therapeutic development L Du, Y He, Y Zhou, S Liu, BJ Zheng, S Jiang Nature Reviews Microbiology 7 (3), 226-236, 2009 | 1980 | 2009 |
| Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to … S Xia, M Liu, C Wang, W Xu, Q Lan, S Feng, F Qi, L Bao, L Du, S Liu, ... Cell research 30 (4), 343-355, 2020 | 1360 | 2020 |
| Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein S Xia, Y Zhu, M Liu, Q Lan, W Xu, Y Wu, T Ying, S Liu, Z Shi, S Jiang, L Lu Cellular & molecular immunology 17 (7), 765-767, 2020 | 781 | 2020 |
| Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion … S Liu, G Xiao, Y Chen, Y He, J Niu, CR Escalante, H Xiong, J Farmar, ... The Lancet 363 (9413), 938-947, 2004 | 608 | 2004 |
| Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine Y He, Y Zhou, S Liu, Z Kou, W Li, M Farzan, S Jiang Biochemical and biophysical research communications 324 (2), 773-781, 2004 | 489 | 2004 |
| Quercetin as an antiviral agent inhibits influenza A virus (IAV) entry W Wu, R Li, X Li, J He, S Jiang, S Liu, J Yang Viruses 8 (1), 6, 2015 | 435 | 2015 |
| N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion S Jiang, H Lu, S Liu, Q Zhao, Y He, AK Debnath Antimicrobial agents and chemotherapy 48 (11), 4349-4359, 2004 | 331 | 2004 |
| Different from the HIV fusion inhibitor C34, the anti-HIV drug Fuzeon (T-20) inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120 S Liu, H Lu, J Niu, Y Xu, S Wu, S Jiang Journal of Biological Chemistry 280 (12), 11259-11273, 2005 | 279 | 2005 |
| SARS vaccine development S Jiang, Y He, S Liu Emerging infectious diseases 11 (7), 1016, 2005 | 276 | 2005 |
| Tannin inhibits HIV-1 entry by targeting gp41 L Lu, SW Liu, SB Jiang, SG Wu Acta Pharmacologica Sinica 25 (2), 213-218, 2004 | 275 | 2004 |
| Identification of N-phenyl-N′-(2, 2, 6, 6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4 Q Zhao, L Ma, S Jiang, H Lu, S Liu, Y He, N Strick, N Neamati, ... Virology 339 (2), 213-225, 2005 | 255 | 2005 |
| Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41 S Liu, H Lu, Q Zhao, Y He, J Niu, AK Debnath, S Wu, S Jiang Biochimica et Biophysica Acta (BBA)-General Subjects 1723 (1-3), 270-281, 2005 | 248 | 2005 |
| Gut microbiota mediates diurnal variation of acetaminophen induced acute liver injury in mice S Gong, T Lan, L Zeng, H Luo, X Yang, NA Li, X Chen, Z Liu, R Li, S Win, ... Journal of hepatology 69 (1), 51-59, 2018 | 199 | 2018 |
| The role of toll-like receptor in inflammation and tumor immunity X Cen, S Liu, K Cheng Frontiers in pharmacology 9, 878, 2018 | 181 | 2018 |
| HIV entry inhibitors targeting gp41: from polypeptides to small-molecule compounds S Liu, S Wu, S Jiang Current pharmaceutical design 13 (2), 143-162, 2007 | 171 | 2007 |
| HIV gp41 C-terminal heptad repeat contains multifunctional domains: relation to mechanisms of action of anti-HIV peptides S Liu, W Jing, B Cheung, H Lu, J Sun, X Yan, J Niu, J Farmar, S Wu, ... Journal of biological chemistry 282 (13), 9612-9620, 2007 | 169 | 2007 |
| Concise and versatile multicomponent synthesis of multisubstituted polyfunctional dihydropyrroles Q Zhu, H Jiang, J Li, S Liu, C Xia, M Zhang Journal of Combinatorial Chemistry 11 (4), 685-696, 2009 | 143 | 2009 |
| Design, Synthesis, and Biological Evaluation of N-Carboxyphenylpyrrole Derivatives as Potent HIV Fusion Inhibitors Targeting gp41 K Liu, H Lu, L Hou, Z Qi, C Teixeira, F Barbault, BT Fan, S Liu, S Jiang, ... Journal of medicinal chemistry 51 (24), 7843-7854, 2008 | 138 | 2008 |
Shibo JiangFudan UniversityVerified email at fudan.edu.cn
